Understanding illicit drug markets, supply-reduction efforts, and drug-related crime in the European Union
The European Drugs Strategy concentrates on demand reduction and supply reduction through international cooperation and research, information and evaluation. However, efforts to provide insight in the different aspects of Europe’s illicit drug problems have largely focused on indicators developed to assess demand-side strategies. The development of measures capturing dimensions of the supply of different illicit substances is an emerging field in the EU. To advance these efforts, the European Commission DG Justice, Freedom and Security commissioned a study to recommend indicators for improving the understanding of illicit drug markets, supply reduction efforts, and drug-related crime in the EU. In this study we reviewed literature and RAND’s previous work in this area, and we gathered insights from European experts and policymakers.
Based on these insights and a conceptual framework for thinking about drug markets, we develop a number of immediate-term, near-term, and long-term recommendations. These recommendations will improve both Member States’ and the European Commission’s ability to monitor drug markets and drug-related crime as well as initiate analyses regarding the effectiveness of supply reduction strategies.
Download eBook for Free
Full Document
| Format | File Size | Notes |
|---|---|---|
| PDF file | 2.2 MB | Use Adobe Acrobat Reader version 7.0 or higher for the best experience. |
Summary Only
| Format | File Size | Notes |
|---|---|---|
| PDF file | 0.3 MB | Use Adobe Acrobat Reader version 7.0 or higher for the best experience. |
Document Details
- Copyright: European Communities
- Publisher: RAND Corporation
- Availability: Web-Only
- Pages: 223
- Document Number: TR-755-EC
- Year: 2010
- Series: Technical Reports
Contents
Chapter One
Executive summary
Chapter Two
Introduction
Chapter Three
A framework for thinking about drug markets
Chapter Four
Indicators for understanding supply-reduction efforts
Chapter Five
Indicators for understanding drug-related crime
Chapter Six
Insights from three case studies
Appendix A
Creating price series without data: Harnessing the power of forensic data
Appendix B
Summary of major publicly-available datasets on drug supply and drug offences in the EU
Appendix C
Data collected about drug prices, purity and seizures in 3rd countries
The research in this report was prepared for the European Commission, DG Justice, Freedom and Security and conducted by RAND Europe.
This report is part of the RAND Corporation technical report series. RAND technical reports may include research findings on a specific topic that is limited in scope or intended for a narrow audience; present discussions of the methodology employed in research; provide literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; or deliver preliminary findings. All RAND reports undergo rigorous peer review to ensure that they meet high standards for research quality and objectivity.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.
RAND® is a registered trademark. Copyright © 1994-2013 RAND Corporation.